<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>23(1)</volume><submitter>Peng LJ</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>T cell acute lymphoblastic leukemia (T-ALL) defines a group of hematological malignancies with heterogeneous aggressiveness and highly variable outcome, making therapeutic decisions a challenging task. We tried to discover new predictive model for T-ALL before treatment by using a specific pipeline designed to discover aberrantly active gene.&lt;h4>Results&lt;/h4>The expression of 18 genes was significantly associated with shorter survival, including ACTRT2, GOT1L1, SPATA45, TOPAZ1 and ZPBP (5-GEC), which were used as a basis to design a prognostic classifier for T-ALL patients. The molecular characterization of the 5-GEC positive T-ALL unveiled specific characteristics inherent to the most aggressive T leukemic cells, including a drastic shut-down of genes located on the mito</pubmed_abstract><journal>BMC genomics</journal><pagination>467</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9233359</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Ectopic expression of a combination of 5 genes detects high risk forms of T-cell acute lymphoblastic leukemia.</pubmed_title><pmcid>PMC9233359</pmcid><pubmed_authors>Zhang JJ</pubmed_authors><pubmed_authors>Mi JQ</pubmed_authors><pubmed_authors>Bourova-Flin E</pubmed_authors><pubmed_authors>Khochbin S</pubmed_authors><pubmed_authors>Cheng ZY</pubmed_authors><pubmed_authors>Chen B</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Geng M</pubmed_authors><pubmed_authors>Zhou YB</pubmed_authors><pubmed_authors>Rousseaux S</pubmed_authors><pubmed_authors>Wang T</pubmed_authors><pubmed_authors>Liu YF</pubmed_authors><pubmed_authors>Peng LJ</pubmed_authors><pubmed_authors>Xi MP</pubmed_authors><pubmed_authors>Chuffart F</pubmed_authors><pubmed_authors>Zhang WN</pubmed_authors><pubmed_authors>Gao MQ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ectopic expression of a combination of 5 genes detects high risk forms of T-cell acute lymphoblastic leukemia.</name><description>&lt;h4>Background&lt;/h4>T cell acute lymphoblastic leukemia (T-ALL) defines a group of hematological malignancies with heterogeneous aggressiveness and highly variable outcome, making therapeutic decisions a challenging task. We tried to discover new predictive model for T-ALL before treatment by using a specific pipeline designed to discover aberrantly active gene.&lt;h4>Results&lt;/h4>The expression of 18 genes was significantly associated with shorter survival, including ACTRT2, GOT1L1, SPATA45, TOPAZ1 and ZPBP (5-GEC), which were used as a basis to design a prognostic classifier for T-ALL patients. The molecular characterization of the 5-GEC positive T-ALL unveiled specific characteristics inherent to the most aggressive T leukemic cells, including a drastic shut-down of genes located on the mito</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2026-05-29T01:07:01.146Z</modification><creation>2024-11-20T17:23:38.532Z</creation></dates><accession>S-EPMC9233359</accession><cross_references><pubmed>35751016</pubmed><doi>10.1186/s12864-022-08688-1</doi></cross_references></HashMap>